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Abstract
Background: The internet is becoming a widely used source of accessing medical research
through various on-line databases. This instant access to information is of benefit to busy clinicians
and service users around the world. The population of the Arab World is comparable to that of
the United States, yet it is widely believed to have a greatly contrasting output of randomised
controlled trials related to mental health. This study was designed to investigate the existence of
such research in the Arab World and also to investigate the availability of this research on-line.
Methods: Survey of findings from three internet-based potential sources of randomised trials
originating from the Arab world and relevant to mental health care.
Results:  A manual search of an Arabic online current contents service identified 3 studies,
MEDLINE, EMBASE, and PsycINFO searches identified only 1 study, and a manual search of a
specifically indexed, study-based mental health database, PsiTri, revealed 27 trials.
Conclusion: There genuinely seem to be few trials from the Arab world and accessing these on-
line was problematic. Replication of some studies that guide psychiatric/psychological practice in
the Arab world would seem prudent.
Background
The well-conducted randomised trial is the gold standard
for the evaluation of medical interventions including
mental health treatments [1]. This methodology was first
formally used in the late 1940's [2] although much earlier
examples do exist http://www.jameslindlibrary.org/
including one controlled experiment from the Middle
East recorded in the Bible about 2nd-1st century BC (Dan-
iel 1:1–16). At first randomised trials were few in number
and easy to summarise but the exponential rise of these
studies made it increasingly difficult to produce clear
unbiased summaries of the best evidence on the effects of
health care interventions [3]. Currently there are thou-
sands of journals worldwide which publish the results of
trials and many thousands of randomised trials reported
each year. Clinicians, trialists, policy makers and patients
cannot hope to keep up with the annual volume of litera-
ture so reviews are useful.
Frequently, reviewing is subjective with little or no
attempt to ensure that the results are reproducible and as
free from bias as possible [3]. More systematic reviews,
however, endeavour to minimise bias and combine the
results of all relevant trials in objective, explicit and
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reproducible ways [4]. This is exemplified by the work of
The Cochrane Collaboration, an international, independ-
ent and not-for-profit organisation which disseminates
systematic reviews of healthcare interventions worldwide
[5]. This Collaboration recognises that including only eas-
ily-identified trials in reviews leaves work vulnerable to
the inclusion of bias, as highly accessible trials tend to be
more positive than those that are more difficult to find [6-
8]. Cochrane reviewers therefore make strenuous efforts
to find all relevant studies-a model that all researchers
would do well to emulate when searching for relevant ran-
domised controlled trials.
The Arab world is a culturally, religiously and ethnically
diverse region consisting of 22 countries from Mauritania
in the west, to Iraq in the east. Its rapidly expanding pop-
ulation is estimated at over 280 million. The media in this
region reports little, except in the context of oil reserves,
religious tensions and conflict. Despite the Arab world
having a population comparable in size to that of the
USA, its contribution to recent global medical literature is
thought to be relatively small [9]. Reasons for this are
probably many and complex, but may include military
conflict and arms expenditure, the 'brain drain', research
culture, trade embargoes and humanitarian crises [9,10].
Table 1: Number of issues available to search electronically in Arab psychiatric journals and number of randomised controlled trials 
identified. Table modified from http://www.arabpsynet.com
Journal Country of 
publication
Language Dates available Total number 
of. issues in 
available dates
No. issues with 
contents pages 
available on this 
site
No. RCTs 
identified on 
available 
content pages
Addiction Bulletin Egypt Arabic 1999–2000 8 4 0
Arabpsynet 
journal
Tunisia Arabic & English 2004–2004 2 2 0
Arab Journal of 
Psychiatry
Jordan English 1989–2003 28 18 2
Arab Psychologist Egypt English 2000–2001 2 2 0
Assaha Al Aklia Yemen Arabic 1999–2001 12 9 0
Bulletin of Egyptian 
Psychiatric 
Association
Egypt Arabic 1999–2001 12 5 0
Current Psychiatry Egypt English 1994–1996 6 3 1
Egyptian Journal of 
Mental Health
Egypt Arabic & English None 0 0 0
Egyptian Journal of 
Psychiatry
Egypt English None 0 0 0
Egyptian Journal of 
Psychological 
Studies
Egypt Arabic 1992–2000 36 1 0
Interdisciplinary 
Psychology
Lebanon Arabic 1990–2004 58 54 0
Journal on Arab 
Children
Kuwait Arabic 1998–2004 24 13 0
Man and Evolution Egypt Arabic 1984–2000 76 41 0
Mental Health Yemen Arabic 1992–2000 18 7 0
Mental Peace 
Journal of WIAMH
Saudi Arabia Arabic 1994–2002 36 12 0
News Letter of 
the AFNGO for 
Drug Abuse 
Prevention
Egypt Arabic 1999–2001 6 2 0
Psychological 
Quarterly
Egypt Arabic 2000–2002 12 4 0
Psychology Egypt Arabic 1987–2002 64 22 0
Tunisian Annals of 
Psychiatry
Tunisia French 1996–1997 4 2 0
Tunisian Journal of 
Psychiatry
Tunisia French 1998–2001 8 1 0
WIAMH 
Newsletter
Egypt English 1998–2003 38 10 0BMC Psychiatry 2005, 5:30 http://www.biomedcentral.com/1471-244X/5/30
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Although a comparatively small proportion of ran-
domised controlled trials are conducted outside of the rel-
atively affluent West, there is evidence that other parts of
the developing world are beginning to make progress.
One particular study looked at randomised controlled tri-
als originating from Sub-Saharan Africa, and showed that
there may have been an increase in publication of these
trials over time. The same article however, identified that
there was a relative lag between the overall burden of
mental illnesses on the continent and trials focussing on
these conditions [11].
This paper describes a search for, and survey of, ran-
domised controlled trials relevant to mental health pub-
lished in the Arab literature or having clearly originated
from one of the countries of the Arab world.
Methods
First we manually searched the ArabPsyNet database
http://www.arabpsynet.com/homepage/psy-reviews.htm
The function of this internet-based database, in part, is as
a current awareness service for the contents of Arab psy-
chiatric and psychological periodicals. The list of journals
and the years for which contents pages are available are
presented in Table 1. An initial search was conducted in
December 2003 and repeated in May 2004. Articles pub-
lished in Arabic, English and French could have been
included. We recognise that publication in Arab World
journals did not necessarily imply the Arabic descent of
authors and, similarly, publication in an Arab world jour-
nal did not necessarily mean that the research was under-
taken in the Arab world.
Next, we manually searched EMBASE, MEDLINE and Psy-
cINFO with " (Randomi* and (arab* or [names of indi-
vidual countries]) and ([broad terms for mental disorder/
illness]))".
Thirdly, we manually searched PsiTri http://psi
tri.stakes.fi/index.html for the name of every Arab country
in the 'country of origin' field. PsiTri is a freely available
based electronic database on published and unpublished
controlled clinical trials, reporting on treatments and
interventions for a wide range of conditions within the
field of mental health. Uniquely, it is study-based, rather
than simply consisting of lists of citations that could relate
to the same study. It is also reliably indexed with country
of origin.
Results
The search of ArabPsyNet identified only three ran-
domised controlled trials which had been published in
the 212 available issues from the 21 journals
between1984 and 2004. If all issues had been available
from all 21 journals we predict that three more studies
would have been identified. All three trials were pub-
lished in English (see Table 1). The first, in the Arab Jour-
nal of Psychiatry in 1989, reports a small randomised
controlled trial of alprazolam versus cognitive therapy for
outpatients with panic disorders [12]. The second, pub-
lished in 1996, also in the Arab Journal of Psychiatry [13]
reports another small randomised controlled trial, this
time comparing zuclopenthixol acetate with haloperidol
for people with schizophrenic psychoses, affective psy-
choses and paranoid states. Finally, the third trial was
published in Current Psychiatry in 1996 and reports a ran-
domised controlled trial of sertaline versus placebo for
over 300 people with obsessive-compulsive disorder [14].
This final trial was not conducted in the Middle East, but
was published in an Egyptian journal.
MEDLINE and EMBASE searches did not identify any of
the three studies. However, one of the studies [13] was
identified through PsycINFO. The majority of studies
included on these three popular databases come from
journals with a high citation index, all of which tend to be
published in the Western world. In this way, the low cita-
tion rate of Arab journals is likely to be perpetuated as
these databases are commonly used in searches.
PsiTri contained most randomised controlled trials rele-
vant to this survey. Searching on country of origin several
relevant articles published outside of Arab journals, some
of which were not in psychiatric or psychological periodi-
cals. In all, we identified 27 randomised controlled trials
from eight Arab countries (see Table 2).
Discussion
ArabPsyNet, the only mental-health specific database
detailing 'table of contents' pages of journals rarely seen
outside of Arabic-speaking world, is making a concerted
effort to disseminate research from the region. As yet the
coverage of journals is limited and varied- as is the infor-
mation produced on each article. As this site develops, its
contribution should become greater. Current searches
suggest that trials from the Arab world are rarely pub-
lished in these journals. The main-stream databases are
also not good sources of mental health trials from this
region and may make the possibility of 'index-bias' more
likely when searching for trial of Arab World origin. It is
possible that we failed to identify studies, as reporting of
country of origin is variable. Further complexity is added
to these searches of general databases by having to use a
phrase covering the many ways mental health problems
are indexed, as well as one for the many country's names
in title, abstract, and address fields. The mental health spe-
cific database, PsiTri, avoided the need for this. Being
study-based and specifically indexed for country of origin
confers great advantage over the other two sources. This
database, as a compilation of all registers of mental healthBMC Psychiatry 2005, 5:30 http://www.biomedcentral.com/1471-244X/5/30
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Cochrane groups (which are themselves created with
extensive searches of many diverse databases) is likely to
be the best source in existence of clearly indexed mental
health studies from the Arab world.
It is possible that we failed to identify relevant trials pub-
lished in Arab journals. Many countries, including The
Czech Republic, Hungary, India, Korea, Latin America,
Russia, and the Ukraine (see Table 3), recognising that
coverage of their home literature in databases such as
MEDLINE will always be limited, produce their own med-
ical bibliographic databases in which searching for ran-
domised trials is relatively simple. We know of no such
database in the Arab world, but such a project would
make a most valuable contribution to dissemination of
medical research from the area.
Lower profile Arab journals may not be able to attract sub-
mission of randomised trials from home or overseas. The
results from PsiTri did suggest that studies from the Arab
world are most often seen in journals outside of the
region. There is evidence from other studies that trials
from non-English speaking countries are more likely to be
published in Anglophone journals if statistically signifi-
cant and those same authors are more likely to publish
their other, less 'significant' studies in their home lan-
guage [15]. We cannot tell how many trials would have
been sent to 'mainstream' journals and rejected and we
would have expected to see them published in the home
literature. We did not. With raised awareness amongst edi-
tors of publication bias due to study origins, we hope this
phenomenon, if contributing to the dearth of accessible
trials from the Arab world becomes less prevalent.
Table 2: Results from PsyTri searching by country of origin
Country in which 
trial was thought to 
be undertaken
No. of 
randomised 
trials
Journal of publication Subject Year
Algeria 1 European Psychiatry Depression [18] 1995
Bahrain 1 Arab Journal of Psychiatry Psychoses [13] 1996
Egypt 12 Journal of International Medical Depression [19] 1980
Research Depression [20] 1976
Journal of International Medical Impotence [21] 1992
Research Journal of Urology Affective disorders [22] 1983
International Journal of Nursing Depression [23] 1976
Studies Enuresis [24] 1999
Journal of the Egyptian Medical Enuresis [25] 1990
Association Pubertal
Urology development [26] 1969
Urology Neurotic Disorders;
American Journal of Clinical Schizophrenia;
Nutrition Depressive
Acta Psychiatrica Scandinavica Disorder; Mental Disorders [27] 1970
Journal of the European College of 
Neuropsychopharmacology
Schizophrenia [28] 1999
British Journal of Psychiatry Schizophrenia [29] 1970
Iraq 2 Journal of Urology Enuresis [30] 1989
Clinical and Experimental Pharmacology & Physiology Enuresis [31] 1986
Lebanon 2 Pediatric Nursing Anxiety [32] 1998
International Journal of Geriatric Psychiatry Alzheimers [33] 2004
Libya 1 Gerontologia Clinica Senile restlessness [34] 1970
Kuwait 3 British Journal of Psychiatry ECT-induced cognitive
Journal of the Kuwait Medical impairement [35] 1985
Association Schizophrenia [36] 1981
Biological Psychiatry Chronic schizophrenia [37] 1999
Saudi Arabia 5 Journal of Clinical Depression [38] 1995
Pharmacology Anxiety [39] 1999
British Journal of Anaesthesia Dental anxiety [40] 1999
Journal of Dental Research Acta Psyhiatrica Scandinivica Psychiatric illness [41] 1997
Behavioural and Cognitive Psychotherapy Schizophrenia [42] 1997BMC Psychiatry 2005, 5:30 http://www.biomedcentral.com/1471-244X/5/30
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Perhaps there are many fewer studies published in the
Arab world than would be expected from the population.
Previous work suggests that population is not a good pre-
dictor of productivity of trials relevant to schizophrenia
[16]. Gross Domestic Product (GDP) proved a much
more potent predictor. The greater the GDP, the greater
the productivity of schizophrenia trials. Assuming this
holds for all mental health trials, one potent factor could
be that many of the Arab countries are in the low income
bracket where output of [at least] schizophrenia trials
would be expected to be low. Even the few richer Arab
countries have a GDP which is focused on oil revenue.
This uneven poverty may well be a factor in the Arab
world's lack of productivity of mental health trials.
Although poverty may be predictive, it is not necessarily
causative and this fact may not fully explain why trial
numbers in other more economically-disadvantaged parts
of the developing world appear to be increasing [11]. Not
all trials are highly expensive. Infrastructure for trials,
however, may be suffering from under investment, and
the culture or political climate may be hostile. One cannot
underestimate the potential effects that culture may play
in clinical trial conduction in the region. These potential
effects may be expected to be seen much more acutely in
the much-stigmatised area of mental health. Many factors
could mediate against evaluative research.
There were a few further areas related to the study on
which the authors would like to make further comment
on.
Although not specifically reported in this study mainly
owing to poor data availability, it may have been useful to
comment on the number of studies which reported statis-
tically significant results- which in turn may give an indi-
cation of potential publication bias. Most of the included
trials did not appear to focus on topics that had a particu-
lar Arab-focus and therefore, notwithstanding issues
around inter-regional validity, results from large, well
designed Western trials (albeit covering similar subject
matters) may provide equally-accurate results on which to
base local service provision. It was difficult to confirm
these observations as we were only able to gain access to
the table-of-contents pages for most of the electronic data-
bases and hence had limited ability to comment on the
regional nature of the research. Although our study
looked only at randomised controlled trials on mental
health, we acknowledge the possibility that valuable
research in other methodological formats may still be
published with an Arab-focus and may provide useful
answers to health questions in the area. The author's also
acknowledge that the overall quality of the reporting of
studies may have been a useful additional measure, how-
ever it was seen as being outside of the remit of this article.
The ethical nature of included studies again could have
been reported on if further data have been available. There
is some evidence that trials conducted in 'resource-poor
settings' may be more likely to include comparator arms
that would be deemed sub-optimal, or even unethical in
the West [17]. Conversely, what is deemed ethical in the
West could be unethical in situations where resources are
not so abundant. Judging the ethics of others by standards
that are not based in local knowledge and culture may be
problematic.
There is also the issue of researchers migrating from the
region. Researchers of Arab origin may leave to work in
more wealthy countries where funding for randomised
controlled trials is more readily available.
Conclusion
Even if we have failed to identify many relevant studies,
there is a suggestion that this large part of the world is not
significantly contributing to evaluative mental health
research. This perceived paucity of randomised controlled
trials on mental health originating from the Middle East
may in part be compounded by the lack of availability and
dissemination of trial results via the internet. The appar-
ent lack of randomised controlled trials in the Arab world
could, in part, be due to a lack of funding. Despite the lack
of randomised controlled trials, researchers in the Arab
world are publishing studies on mental health issues.
Although our research has highlighted the limited num-
bers of relevant trials accessible through the internet, it
should be noted that there may be a substantial body of
work being conducted and published in other formats.
Creating a regional database may provide researchers with
greater trial accessibility and hence locate a hitherto-
'untapped well' of information.
Table 3: Bibliographic and full text sources by country/region of 
origin.*
AFRICA [43]
CHINA [44]
CZECH REPUBLIC [45]
EASTERN MEDITERRANEAN [46]
EGYPT [47]
FRANCE [48]
HUNGARY [49]
INDIA [50]
KOREA [51]
LATIN AMERICA [52]
POLAND [53]
RUSSIA [54] [55] [56]
SAUDI ARABIA [57]
THAILAND [58] [59] [60] [61]
UKRAINE [62]
* This list is not meant to be comprehensive – but is presented at 
request of peer review to illustrate the wealth of sources for 
bibliographic registers of biomedical literatureBMC Psychiatry 2005, 5:30 http://www.biomedcentral.com/1471-244X/5/30
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